Ivermectin: A Closer Look at a Potential Remedy

{ 'indexed': {'date-parts': [[2023, 1, 7]], 'date-time': '2023-01-07T22:51:47Z', 'timestamp': 1673131907825}, 'reference-count': 28, 'publisher': 'Cureus, Inc.', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2020, 9, 11]]}, 'DOI': '10.7759/cureus.10378', 'type': 'journal-article', 'created': {'date-parts': [[2020, 9, 11]], 'date-time': '2020-09-11T15:05:02Z', 'timestamp': 1599836702000}, 'source': 'Crossref', 'is-referenced-by-count': 1, 'title': 'Ivermectin: A Closer Look at a Potential Remedy', 'prefix': '10.7759', 'author': [ {'given': 'Karim O', 'family': 'Elkholy', 'sequence': 'first', 'affiliation': []}, {'given': 'Omar', 'family': 'Hegazy', 'sequence': 'additional', 'affiliation': []}, {'given': 'Burak', 'family': 'Erdinc', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hesham', 'family': 'Abowali', 'sequence': 'additional', 'affiliation': []}], 'member': '4492', 'reference': [ { 'key': 'ref1', 'unstructured': 'WHO Coronavirus Disease (COVID-19) Dashboard. (2020). ' 'http.//coronavirus.jhu.edu/map.html.'}, { 'key': 'ref2', 'doi-asserted-by': 'publisher', 'article-title': 'Morphology, Genome Organization, Replication, and Pathogenesis of ' 'Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)', 'author': 'Kumar S', 'year': '2020', 'unstructured': 'Kumar S, Nyodu R, Maurya V, Saxena SK. Morphology, Genome Organization, ' 'Replication, and Pathogenesis of Severe Acute Respiratory Syndrome ' 'Coronavirus 2 (SARS-CoV-2). Coronavirus Disease 2019 (COVID-19). ' 'Epidemiology, Pathogenesis, Diagnosis, and Therapeutics. Saxena SK (ed): ' 'Springer, Singapore; 2020. 23-31. 10.1007/978-981-15-4814-7_3', 'DOI': '10.1007/978-981-15-4814-7_3'}, { 'key': 'ref3', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/s0046-8177(03)00367-8', 'article-title': 'Lung pathology of severe acute respiratory syndrome (SARS): a study of ' '8 autopsy cases from Singapore', 'volume': '34', 'author': 'Franks TJ', 'year': '2003', 'unstructured': 'Franks TJ, Chong PY, Chui P, et al.. Lung pathology of severe acute ' 'respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. ' 'Hum Pathol. 2003, 34:743-748. 10.1016/s0046-8177(03)00367-8', 'journal-title': 'Hum Pathol'}, { 'key': 'ref4', 'doi-asserted-by': 'publisher', 'DOI': '10.3201/eid2609.202095', 'article-title': 'Pathology and pathogenesis of SARS-CoV-2 associated with fatal ' 'coronavirus disease, United States', 'volume': '26', 'author': 'Martines RB', 'year': '2020', 'unstructured': 'Martines RB, Ritter JM, Matkovic E, et al.. Pathology and pathogenesis ' 'of SARS-CoV-2 associated with fatal coronavirus disease, United States. ' 'Emerg Infect Dis. 2020, 26:2005-2015. 10.3201/eid2609.202095', 'journal-title': 'Emerg Infect Dis'}, { 'key': 'ref5', 'unstructured': 'CDC Public Health Image Library (PHIL) #23312. (2020). Accessed. August ' '31, 2020: http://phil.cdc.gov/Details.aspx?pid=23312.'}, { 'key': 'ref6', 'doi-asserted-by': 'publisher', 'DOI': '10.1074/jbc.AC120.013056', 'article-title': 'The antiviral compound remdesivir potently inhibits RNA-dependent RNA ' 'polymerase from Middle East respiratory syndrome coronavirus', 'volume': '295', 'author': 'Gordon CJ', 'year': '2020', 'unstructured': 'Gordon CJ, Tchesnokov EP, Feng JY, Porter DP, Götte M. The antiviral ' 'compound remdesivir potently inhibits RNA-dependent RNA polymerase from ' 'Middle East respiratory syndrome coronavirus. J Biol Chem. 2020, ' '295:4773-4779. 10.1074/jbc.AC120.013056', 'journal-title': 'J Biol Chem'}, { 'key': 'ref7', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/nejmoa2007764', 'article-title': 'Remdesivir for the treatment of Covid-19 — preliminary report', 'volume': '{Epub ahead of print}', 'author': 'Beigel JH', 'year': '2020', 'unstructured': 'Beigel JH, Tomashek KM, Dodd LE, et al.. Remdesivir for the treatment of ' 'Covid-19 — preliminary report. N Engl J Med. 2020, {Epub ahead of ' 'print}:NEJMoa2007764. 10.1056/nejmoa2007764', 'journal-title': 'N Engl J Med'}, { 'key': 'ref8', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/s0149-2918(96)80063-4', 'article-title': 'Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of ' 'action and comparison with zidovudine', 'volume': '18', 'author': 'Chiang G', 'year': '1996', 'unstructured': 'Chiang G, Sassaroli M, Louie M, Chen H, Stecher VJ, Sperber K. ' 'Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of ' 'action and comparison with zidovudine. Clin Ther. 1996, 18:1080-1092. ' '10.1016/s0149-2918(96)80063-4', 'journal-title': 'Clin Ther'}, { 'key': 'ref9', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ijantimicag.2020.105960', 'article-title': 'Structural and molecular modelling studies reveal a new mechanism of ' 'action of chloroquine and hydroxychloroquine against SARS-CoV-2 ' 'infection', 'volume': '55', 'author': 'Fantini J', 'year': '2020', 'unstructured': 'Fantini J, Di Scala C, Chahinian H, Yahi N. Structural and molecular ' 'modelling studies reveal a new mechanism of action of chloroquine and ' 'hydroxychloroquine against SARS-CoV-2 infection. Int J Antimicrob ' 'Agents. 2020, 55:105960. 10.1016/j.ijantimicag.2020.105960', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': 'ref10', 'unstructured': 'NIH halts clinical trial of hydroxychloroquine. (2020). ' 'http.//www.nih.gov/news-events/news-releases/nih-halts-clinical-trial-hydroxychloroquine.'}, { 'key': 'ref11', 'unstructured': 'WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment ' 'arms for COVID-19. (2020). Accessed. August 31, 2020: ' 'http://www.who.int/news-room/detail/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-....'}, { 'key': 'ref12', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/cpt.1844', 'article-title': 'Favipiravir: pharmacokinetics and concerns about clinical trials for ' '2019-nCoV infection', 'volume': '108', 'author': 'Du YX', 'year': '2020', 'unstructured': 'Du YX, Chen XP. Favipiravir: pharmacokinetics and concerns about ' 'clinical trials for 2019-nCoV infection. Clin Pharmacol Ther. 2020, ' '108:242-247. 10.1002/cpt.1844', 'journal-title': 'Clin Pharmacol Ther'}, { 'key': 'ref13', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2013.09.015', 'article-title': 'Favipiravir (T-705), a novel viral RNA polymerase inhibitor', 'volume': '100', 'author': 'Furuta Y', 'year': '2013', 'unstructured': 'Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF, Barnard DL. ' 'Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral ' 'Res. 2013, 100:446-454. 10.1016/j.antiviral.2013.09.015', 'journal-title': 'Antiviral Res'}, { 'key': 'ref14', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.eng.2020.03.007', 'article-title': 'Experimental treatment with favipiravir for COVID-19: an open-label ' 'control study', 'volume': '{Epub ahead of print}', 'author': 'Cai Q', 'year': '2020', 'unstructured': 'Cai Q, Yang M, Liu D, et al.. Experimental treatment with favipiravir ' 'for COVID-19: an open-label control study. Engineering (Beijing). 2020, ' '{Epub ahead of print}:10.1016/j.eng.2020.03.007. ' '10.1016/j.eng.2020.03.007', 'journal-title': 'Engineering (Beijing)'}, { 'key': 'ref15', 'doi-asserted-by': 'publisher', 'DOI': '10.1208/s12248-007-9000-9', 'article-title': 'The pharmacokinetics and interactions of ivermectin in humans--a ' 'mini-review', 'volume': '10', 'author': 'González Canga A', 'year': '2008', 'unstructured': 'González Canga A, Sahagún Prieto AM, Diez Liébana MJ, Fernández Martínez ' 'N, Sierra Vega M, García Vieitez JJ. The pharmacokinetics and ' 'interactions of ivermectin in humans--a mini-review. AAPS J. 2008, ' '10:42-46. 10.1208/s12248-007-9000-9', 'journal-title': 'AAPS J'}, { 'key': 'ref16', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s00210-020-01902-5', 'article-title': 'Ivermectin, antiviral properties and COVID- 19: a possible new ' 'mechanism of action', 'volume': '393', 'author': 'Rizzo E', 'year': '2020', 'unstructured': 'Rizzo E. Ivermectin, antiviral properties and COVID- 19: a possible new ' 'mechanism of action. Naunyn Schmiedebergs Arch Pharmacol. 2020, ' '393:1153-1156. 10.1007/s00210-020-01902-5', 'journal-title': 'Naunyn Schmiedebergs Arch Pharmacol'}, { 'key': 'ref17', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2020.104760', 'article-title': 'The broad spectrum antiviral ivermectin targets the host nuclear ' 'transport importin α/β1 heterodimer', 'volume': '177', 'author': 'Yang SNY', 'year': '2020', 'unstructured': 'Yang SNY, Atkinson SC, Wang C, Lee A, Bogoyevitch MA, Borg NA, Jans DA. ' 'The broad spectrum antiviral ivermectin targets the host nuclear ' 'transport importin α/β1 heterodimer. Antiviral Res. 2020, 177:104760. ' '10.1016/j.antiviral.2020.104760', 'journal-title': 'Antiviral Res'}, { 'key': 'ref18', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.virusres.2005.05.007', 'article-title': 'Nuclear/nucleolar localization properties of C-terminal nucleocapsid ' 'protein of SARS coronavirus', 'volume': '114', 'author': 'Timani KA', 'year': '2005', 'unstructured': 'Timani KA, Liao Q, Ye L, et al.. Nuclear/nucleolar localization ' 'properties of C-terminal nucleocapsid protein of SARS coronavirus. Virus ' 'Res. 2005, 114:23-34. 10.1016/j.virusres.2005.05.007', 'journal-title': 'Virus Res'}, { 'key': 'ref19', 'doi-asserted-by': 'publisher', 'DOI': '10.1128/jvi.75.1.506-512.2001', 'article-title': 'The coronavirus infectious bronchitis virus nucleoprotein localizes to ' 'the nucleolus', 'volume': '75', 'author': 'Hiscox JA', 'year': '2001', 'unstructured': 'Hiscox JA, Wurm T, Wilson L, Britton P, Cavanagh D, Brooks G. The ' 'coronavirus infectious bronchitis virus nucleoprotein localizes to the ' 'nucleolus. J Virol. 2001, 75:506-512. 10.1128/jvi.75.1.506-512.2001', 'journal-title': 'J Virol'}, { 'key': 'ref20', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fmicb.2015.00553\xa0', 'article-title': 'Nucleocytoplasmic transport of nucleocapsid proteins of enveloped RNA ' 'viruses', 'volume': '6', 'author': 'Wulan WN', 'year': '2015', 'unstructured': 'Wulan WN, Heydet D, Walker EJ, Gahan ME, Ghildyal R. Nucleocytoplasmic ' 'transport of nucleocapsid proteins of enveloped RNA viruses. Front ' 'Microbiol. 2015, 6:553. 10.3389/fmicb.2015.00553\xa0', 'journal-title': 'Front Microbiol'}, { 'key': 'ref21', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2020.104787', 'article-title': 'The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 ' 'in vitro', 'volume': '178', 'author': 'Caly L', 'year': '2020', 'unstructured': 'Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ' 'ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral ' 'Res. 2020, 178:104787. 10.1016/j.antiviral.2020.104787', 'journal-title': 'Antiviral Res'}, { 'key': 'ref22', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/cpt.1889', 'article-title': 'The approved dose of ivermectin alone is not the ideal dose for the ' 'treatment of COVID‐19', 'volume': '{Epub ahead of print}', 'author': 'Schmith VD', 'year': '2020', 'unstructured': 'Schmith VD, Zhou JJ, Lohmer LRL. The approved dose of ivermectin alone ' 'is not the ideal dose for the treatment of COVID‐19. Clin Pharmacol ' 'Ther. 2020, {Epub ahead of print}:10.1002/cpt.1889. 10.1002/cpt.1889', 'journal-title': 'Clin Pharmacol Ther'}, { 'key': 'ref23', 'doi-asserted-by': 'publisher', 'DOI': '10.1101/2020.06.06.20124461', 'article-title': 'ICON (Ivermectin in COvid Nineteen) study: use of ivermectin is ' 'associated with lower mortality in hospitalized patients with COVID19 ' '[PREPRINT]', 'author': 'Rajter JC', 'year': '2020', 'unstructured': 'Rajter JC, Sherman M, Fatteh N, Vogel F, Sacks J, Rajter JJ. ICON ' '(Ivermectin in COvid Nineteen) study: use of ivermectin is associated ' 'with lower mortality in hospitalized patients with COVID19 [PREPRINT]. ' 'medRxiv. 2020, 2020.06.06.20124461. 10.1101/2020.06.06.20124461', 'journal-title': 'medRxiv'}, { 'key': 'ref24', 'doi-asserted-by': 'publisher', 'DOI': '10.1183/1393003.congress-2017.PA4125', 'article-title': 'PA4125: Dry powder inhaled ribavirin in healthy volunteers: safety, ' 'tolerability, lung and systemic pharmacokinetics', 'volume': '50', 'author': 'Billiard J', 'year': '2017', 'unstructured': 'Billiard J, Baker S, Chandrasekaran V, van den Berg F, Yang S, Dumont E. ' 'PA4125: Dry powder inhaled ribavirin in healthy volunteers: safety, ' 'tolerability, lung and systemic pharmacokinetics. Eur Respir J. 2017, ' '50:4125. 10.1183/1393003.congress-2017.PA4125', 'journal-title': 'Eur Respir J'}, { 'key': 'ref25', 'doi-asserted-by': 'publisher', 'DOI': '10.1086/315392', 'article-title': 'Rapid antiviral effect of inhaled zanamivir in the treatment of ' 'naturally occurring influenza in otherwise healthy adults', 'volume': '181', 'author': 'Boivin G', 'year': '2000', 'unstructured': 'Boivin G, Goyette N, Hardy I, Aoki F, Wagner A, Trottier S. Rapid ' 'antiviral effect of inhaled zanamivir in the treatment of naturally ' 'occurring influenza in otherwise healthy adults. J Infect Dis. 2000, ' '181:1471-1474. 10.1086/315392', 'journal-title': 'J Infect Dis'}, { 'key': 'ref26', 'doi-asserted-by': 'publisher', 'DOI': '10.1155/2018/2732017', 'article-title': 'Inhaled therapy in respiratory disease: the complex interplay of ' 'pulmonary kinetic processes', 'volume': '2018', 'author': 'Borghardt JM', 'year': '2018', 'unstructured': 'Borghardt JM, Kloft C, Sharma A. Inhaled therapy in respiratory disease: ' 'the complex interplay of pulmonary kinetic processes. Can Respir J. ' '2018, 2018:2732017. 10.1155/2018/2732017', 'journal-title': 'Can Respir J'}, { 'key': 'ref27', 'article-title': 'Determination of ivermectin in human plasma by high-performance liquid ' 'chromatography', 'volume': '43', 'author': 'Krishna DR', 'year': '1993', 'unstructured': 'Krishna DR, Klotz U. Determination of ivermectin in human plasma by ' 'high-performance liquid chromatography. Arzneimittelforschung. 1993, ' '43:609-611.', 'journal-title': 'Arzneimittelforschung'}, { 'key': 'ref28', 'article-title': 'Study on the subacute inhalation toxicity of ivermectin TC in rats', 'volume': '26', 'author': 'Ji L', 'year': '2016', 'unstructured': 'Ji L, Cen J, Lin S, Hu C, Fang H, Xu J, Chen J. Study on the subacute ' 'inhalation toxicity of ivermectin TC in rats. Chinese J Comp Med. 2016, ' '26:70-74.', 'journal-title': 'Chinese J Comp Med'}], 'container-title': 'Cureus', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.cureus.com/articles/37039-ivermectin-a-closer-look-at-a-potential-remedy', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2020, 9, 11]], 'date-time': '2020-09-11T15:05:06Z', 'timestamp': 1599836706000}, 'score': 1, 'resource': { 'primary': { 'URL': 'https://www.cureus.com/articles/37039-ivermectin-a-closer-look-at-a-potential-remedy'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 9, 11]]}, 'references-count': 28, 'URL': 'http://dx.doi.org/10.7759/cureus.10378', 'relation': {}, 'ISSN': ['2168-8184'], 'subject': ['Aerospace Engineering'], 'published': {'date-parts': [[2020, 9, 11]]}}